Investments in and Advances to Joint Ventures (Tables)

3 Months Ended

Mar. 31, 2024

Equity Method Investments and Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	March 31, 2024		December 31, 2023
Current assets	$	441,446	$	426,633
Noncurrent assets		13,011		14,295
Total assets		454,457		440,928
Current liabilities		263,690		260,286
Noncurrent liabilities		4,211		5,132
Total liabilities		267,901		265,418
Total joint venture equity	$	186,556	$	175,510

	Three Months Ended
	March 31, 2024		March 31, 2023
Revenue	$	202,017	$	161,484
Costs		171,148		141,598
Net income	$	30,869	$	19,886
Net income attributable to noncontrolling interests	$	15,243	$	9,723

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	March 31, 2024		December 31, 2023
Current assets	$	1,620,565	$	1,607,953
Noncurrent assets		475,188		483,693
Total assets		2,095,753		2,091,646
Current liabilities		1,040,231		1,057,113
Noncurrent liabilities		509,299		518,647
Total liabilities		1,549,530		1,575,760
Total joint venture equity	$	546,223	$	515,886
Investments in and advances to unconsolidated joint ventures	$	145,043	$	128,204

	Three Months Ended
	March 31, 2024			March 31, 2023
Revenue	$	473,532		$	349,157
Costs		476,750			359,395
Net income (loss)	$	(3,218	)	$	(10,238	)
Equity in losses of unconsolidated joint ventures	$	(2,060	)	$	(5,840	)

Summary of Financial Statement Impact From Changes In Estimates on an Unconsolidated Joint Ventures

The following table presents certain financial statement impacts from changes in estimates on unconsolidated joint ventures in the Critical Infrastructure segment.

	March 31, 2024			March 31, 2023
Operating loss	$	(8,361	)	$	(6,840	)
Net loss		(6,258	)		(5,121	)
Diluted loss per share	$	(0.06	)	$	(0.04	)